Joelle Vermeulen
Overview
Explore the profile of Joelle Vermeulen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
983
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zeka F, Decock A, Van Goethem A, Vanderheyden K, Demuynck F, Lammens T, et al.
JCI Insight
. 2018 Dec;
3(23).
PMID: 30518699
In this study, the circulating miRNome from diagnostic neuroblastoma serum was assessed for identification of noninvasive biomarkers with potential in monitoring metastatic disease. After determining the circulating neuroblastoma miRNome, 743...
2.
Decock A, Ongenaert M, Hoebeeck J, De Preter K, Van Peer G, Van Criekinge W, et al.
Genome Biol
. 2012 Oct;
13(10):R95.
PMID: 23034519
Background: Accurate outcome prediction in neuroblastoma, which is necessary to enable the optimal choice of risk-related therapy, remains a challenge. To improve neuroblastoma patient stratification, this study aimed to identify...
3.
De Preter K, Mestdagh P, Vermeulen J, Zeka F, Naranjo A, Bray I, et al.
Clin Cancer Res
. 2011 Oct;
17(24):7684-92.
PMID: 22031095
Purpose: More accurate assessment of prognosis is important to further improve the choice of risk-related therapy in neuroblastoma (NB) patients. In this study, we aimed to establish and validate a...
4.
Mestdagh P, Lefever S, Pattyn F, Ridzon D, Fredlund E, Fieuw A, et al.
Nucleic Acids Res
. 2011 Aug;
39(20):e136.
PMID: 21835775
While a growing body of evidence implicates regulatory miRNA modules in various aspects of human disease and development, insights into specific miRNA function remain limited. Here, we present an innovative...
5.
Abel F, Dalevi D, Nethander M, Jornsten R, De Preter K, Vermeulen J, et al.
Cancer Cell Int
. 2011 Apr;
11:9.
PMID: 21492432
Background: There are currently three postulated genomic subtypes of the childhood tumour neuroblastoma (NB); Type 1, Type 2A, and Type 2B. The most aggressive forms of NB are characterized by...
6.
Vermeulen J, De Preter K, Lefever S, Nuytens J, De Vloed F, Derveaux S, et al.
Nucleic Acids Res
. 2011 Feb;
39(9):e63.
PMID: 21317187
Compromised RNA quality is suggested to lead to unreliable results in gene expression studies. Therefore, assessment of RNA integrity and purity is deemed essential prior to including samples in the...
7.
De Brouwer S, De Preter K, Kumps C, Zabrocki P, Porcu M, Westerhout E, et al.
Clin Cancer Res
. 2010 Aug;
16(17):4353-62.
PMID: 20719933
Purpose: Activating mutations of the anaplastic lymphoma kinase (ALK) were recently described in neuroblastoma. We carried out a meta-analysis of 709 neuroblastoma tumors to determine their frequency and mutation spectrum...
8.
Vermeulen J, De Preter K, Mestdagh P, Laureys G, Speleman F, Vandesompele J
Discov Med
. 2010 Jul;
10(50):29-36.
PMID: 20670596
One of the main challenges in clinical cancer research remains to be accurate outcome prediction at the time of diagnosis. Although not frequent in absolute terms, neuroblastoma represents an important...
9.
Oberthuer A, Hero B, Berthold F, Juraeva D, Faldum A, Kahlert Y, et al.
J Clin Oncol
. 2010 Jun;
28(21):3506-15.
PMID: 20567016
Purpose: To evaluate the impact of a predefined gene expression-based classifier for clinical risk estimation and cytotoxic treatment decision making in neuroblastoma patients. Patients And Methods: Gene expression profiles of...
10.
Schulte J, Schowe B, Mestdagh P, Kaderali L, Kalaghatgi P, Schlierf S, et al.
Int J Cancer
. 2010 May;
127(10):2374-85.
PMID: 20473924
For neuroblastoma, the most common extracranial tumour of childhood, identification of new biomarkers and potential therapeutic targets is mandatory to improve risk stratification and survival rates. MicroRNAs are deregulated in...